Gene · 10644
Papers3,666
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,666
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. | Int J Biol Sci | 2025 | 40860196 | PubTator, text mining | PubMed |
| Clinical and prognostic significance of m6A hypomethylation and IGF2BP3 overexpression in gastric cancer: an integrated epigenomic-transcriptomic analysis. | Hum Genomics | 2025 | 40847370 | PubTator, text mining | PubMed |
| Role of ebv-circRPMS1-p53 interaction in the proliferation and clinical progression of Epstein-Barr virus-associated gastric carcinoma. | Virus Res | 2025 | 40846151 | PubTator, text mining | PubMed |
| Circ_0000847 promotes the migration, invasion, and EMT process in colorectal cancer through binding to IGF2BP2 to enhance IGF2 mRNA stability. | Med Oncol | 2025 | 40844647 | PubTator, text mining | PubMed |
| The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis. | J Cancer Res Clin Oncol | 2025 | 40844552 | PubTator, text mining | PubMed |
| Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis. | FASEB J | 2025 | 40838537 | PubTator, text mining | PubMed |
| Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. | Diabetes Metab Res Rev | 2025 | 40831067 | PubTator, text mining | PubMed |
| A deep learning model to predict glioma recurrence using integrated genomic and clinical data. | Commun Med (Lond) | 2025 | 40830273 | PubTator, text mining | PubMed |
| Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. | Cell Death Discov | 2025 | 40830264 | PubTator, text mining | PubMed |
| Correction to: CircEXOC5 Aggravates Sepsis-Induced Acute Lung Injury by Promoting Ferroptosis Through the IGF2BP2/ATF3 Axis. | J Infect Dis | 2025 | 40828520 | PubTator, text mining | PubMed |
| LOR Regulated by METTL3 Alleviates Lipopolysaccharides-Induced Periodontitis Injury. | J Microbiol Biotechnol | 2025 | 40825668 | PubTator, text mining | PubMed |
| Epigenetic control in thyroid cancer: mechanisms and clinical perspective. | Cell Death Discov | 2025 | 40819127 | PubTator, text mining | PubMed |
| Transcriptome profiling and weighted gene co-expression network analysis reveal changes of hub genes and molecular pathways in rat lungs following deep hypothermic circulatory arrest. | PLoS One | 2025 | 40811488 | PubTator, text mining | PubMed |
| Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway. | Sex Med | 2025 | 40808867 | PubTator, text mining | PubMed |
| hsa_circ_0004276 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells and exacerbates postmenopausal osteoporosis through interaction with ELAVL1. | Clinics (Sao Paulo) | 2025 | 40803272 | PubTator, text mining | PubMed |
| IGF2BP2 Facilitates DDP Resistance in NSCLC Through Stabilizing SEZ6L2 Expression. | J Biochem Mol Toxicol | 2025 | 40801328 | PubTator, text mining | PubMed |
| CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance. | Mol Cancer | 2025 | 40784877 | PubTator, text mining | PubMed |
| METTL3 stabilizes DDX17 mRNA via IGF2BP2-mediated m6A modification to suppress endometrial cancer progression. | Clin Exp Med | 2025 | 40775333 | PubTator, text mining | PubMed |
| Regulatory roles of 13 types of RNA modifications in osteoarthritis: based on bulk and single-cell RNA analysis. | 3 Biotech | 2025 | 40771586 | PubTator, text mining | PubMed |
| Ferroptosis: a key driver and therapeutic target in the pathogenesis of acute respiratory distress syndrome. | Front Immunol | 2025 | 40766305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10644/papers?page=11